A 96-week efficacy and safety of BIC/FTC/TAF in ART-naïve HIV-1 infected patients in China.

A 96-week efficacy and safety of BIC/FTC/TAF in ART-naïve HIV-1 infected patients in China. | DocHero AI - Best paraphrasing and translation tool for academic and professional writing